A GLP-1 receptor blockade markedly attenuated the effect of a GCGR blockade to reduce hyperglycemia and EGP in STZ-induced diabetic mice (23) as well as in db/db mice (24). The gene discussed is GCGR; the disease is Hyperglycemia.